Resmed Inc. buy UBS Group AG
Start price
20.09.25
/
50%
€234.30
Target price
20.09.26
-
Performance (%)
-9.35%
Price
18:39
€212.40
Summary
This prediction is currently active. With a performance of -9.35%, the BUY prediction for Resmed Inc. by UBS_Group_AG is down slightly. This prediction currently runs until 20.09.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | 1.454% | 1.454% |
| iShares Core DAX® | 2.032% | 3.499% |
| iShares Nasdaq 100 | -0.145% | -1.849% |
| iShares Nikkei 225® | 4.507% | 1.976% |
| iShares S&P 500 | 0.331% | -0.103% |
Comments by UBS_Group_AG for this prediction
In the thread Resmed Inc. diskutieren
ResMed (NYSE:RMD) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
Ratings data for RMD provided by MarketBeat